Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,207Revenue $M1.4Net Margin (%)-6,941.3Altman Z-Score59.8
Enterprise Value $M1,077EPS $-0.3Operating Margin %-7,746.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)-6,941.3Higher ROA y-yN
Price/Book10.410-y EBITDA Growth Rate %-13.2Quick Ratio12.5Cash flow > EarningsY
Price/Sales6805-y EBITDA Growth Rate %-0.1Current Ratio12.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-145.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-185.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M128ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJoel Greenblatt 2015-03-31 Buy 0.01%$4.96 - $14
($9.88)
$ 9.42-5%New holding109,080
ZIOPFirst Eagle Investment 2013-06-30 Sold Out $1.52 - $2.621
($1.85)
$ 9.42409%Sold Out0
ZIOPFirst Eagle Investment 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 9.42113%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.757.66view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.5169.14view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.281.15view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.9988.78view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.9291.46view
Fowler WycheDirector 2011-08-10Buy5,000$5.1981.5view
KIRK RANDAL JDirector, 10% Owner 2011-08-09Buy846,522$4.7897.07view
WEISER MICHAELDirector 2011-05-25Sell15,000$6.5344.26view
BRENNAN MURRAYDirector 2011-05-09Sell15,000$6.5743.38view
KIRK RANDAL JDirector, 10% Owner 2011-02-03Buy1,910,000$5.7563.83view

Press Releases about ZIOP :

    Quarterly/Annual Reports about ZIOP:

    News about ZIOP:

    Articles On GuruFocus.com
    Holdings Mar 31 2015 
    Holdings Mar 31 2015 
    Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
    Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
    The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 
    comment on ZIOP Mar 15 2013 
    cooldecency99 note on ZIOP May 01 2010 
    ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs Aug 14 2009 

    More From Other Websites
    5 Stocks Under $10 Ready to Spike Higher May 29 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... May 15 2015
    ZIOPHARM ONCOLOGY INC Financials May 15 2015
    10-Q for ZIOPHARM Oncology, Inc. May 09 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 07 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 10-Q, Quarterly Report May 07 2015
    ZIOPHARM Reports First-Quarter 2015 Financial Results and Recent Activities May 07 2015
    ZIOPHARM Appoints Laurence J. N. Cooper, M.D., Ph.D., Chief Executive Officer May 07 2015
    Safety switches may redeem potent CAR T cancer therapies May 07 2015
    ZIOPHARM Announces Initiation of Phase 1 Study of Ad-RTS-IL-12 Gene Therapy in Patients With Brain... May 05 2015
    Call buyers come back to Ziopharm Apr 30 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 27 2015
    ZIOPHARM Announces Initiation of Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With... Apr 27 2015
    Four one-time biotech underdogs are outperforming the market this year Apr 22 2015
    Ziopharm Oncology (ZIOP) Stock Falls Today on Mediocre Solid Tumor Therapy Data Apr 20 2015
    Big biotech movers: Juno & Kite Apr 20 2015
    Lightning Round: I say this is an opportunity Apr 13 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Apr 02 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 01 2015
    Intrexon-Merck KGaA Team Up for CAR-T Cancer Therapies - Analyst Blog Mar 31 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK